CGON CG Oncology, Inc.
$72.35▲ +0.49%
Healthcare
Other
After hours
$72.35▲ +0.00%
Sep 11, 7:30 PM ET
Volume 759.8K
Avg Volume (10D) 588.1K
Key Metrics & Fundamentals
Market Cap
$6.41B
P/E Ratio
–
Div Yield
–%
52W Range
32.57 - 80.97
% vs 50 MA
-2.27%
% vs 200 MA
16.96%
RSI-14
42.5
MACD Histogram
-0.8500
Beta (1Y vs SPY)
1.13
Free Cash Flow
-$46.88M
Gross Rev
$1.16M
Gross Profit
-$2.77M
EBITDA
-$85.55M
COGS
$3.93M
Operating Exp
$83.63M
Operating Income
-$86.40M
EBIT
-$86.40M
Pretax Income
-$79.06M
Net Income
-$79.06M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
3 Stocks Call Traders Are Targeting Today
Schaeffer's Investment Research · Sep 11, 2026 3:35 PM
CG Oncology (CGON) Stock Looks Fully Priced After A 160% Run
Simply Wall St. · Sep 3, 2026 1:06 PM
CG Oncology to Present at Upcoming Investor Conferences in September
GlobeNewswire · Sep 2, 2026 12:00 PM
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
PR Newswire · Aug 26, 2026 2:41 PM
BofA Adjusts Price Target on CG Oncology to $88 From $87
MT Newswires · Aug 7, 2026 12:10 PM
RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating
MT Newswires · Aug 7, 2026 11:15 AM
CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
CG Oncology Q2 Net Loss Widens
MT Newswires · Aug 6, 2026 12:39 PM
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 6, 2026 12:15 PM
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid Renewed Pressure on Semiconductor Stocks
MT Newswires · Jul 28, 2026 1:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CGON's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.